Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 5Phase 1/2 3Phase NA 2Phase 3 2Phase 2/3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Stomach Neoplasms 5Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Pancreatic Neoplasms 2Melanoma 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Sarcoma, Ewing 1SCLC 1Retinoblastoma 1Osteosarcoma 1Oligometastatic Disease 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Carcinoma 1NSCLC 1Mouth Neoplasms 1Lymphoma, Follicular 1Lymphoma 1Locally Advanced Resectable Rectal Cancer 1Kidney Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1

Interventions

Temozolomide 8Lomustine 4vocimagene amiretrorepvec 2Radiation 2veliparib 1tinostamustine 1regorafenib 1carbon-11 acetate 1antisecretory factor 1Sunitinib 1Standard of Care 1Radiotherapy 1Magnetic Resonance Spectroscopy 1Irinotecan 1GDC-0084 1Flucytosine 1Etoposide 1Drug Therapy 1Disulfiram 1Dianhydrogalactitol 1DNA 1Copper 1Carbon-11 1Bevacizumab 1Alkylating Agents 1AZD1390 1ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Glioblastoma × Drug Therapy × Clear all
NCT03008148 2021-05-11

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

Johnpro Biotech, Inc.

Phase 2/3 Unknown
288 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡